Becton, Dickinson and Co. | BDX - Frais De Vente Et D'Administration

Prix De L'Action
152.14
Variation Quotidienne
-2.71 -1.75%
Mensuellement
-3.87%
Annuel
-25.81%
Q2 Prévisions
148.88




Frais De Vente Et D'Administration Changement Date
Abbott USD 3.27B 138M 2026-03
Agilent USD 476M 48M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
AngioDynamics USD 36.57M 3.79M 2025-09
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bio-Rad Laboratories USD 206.8M 900K 2025-09
Boston Scientific USD 1.83B 93M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 383M 28M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Solventum Corp USD 759M 15M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Terumo JPY 105.26B 7.38B 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12